Search Medical Condition
Please enter condition
Please choose location

Liver Disease Clinical Trials

A listing of Liver Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (450) clinical trials

People who have Nonalcoholic Steatohepatitis (NASH) and cirrhosis (F4 fibrosis) are asked to participate in a research study being conducted by North Shore University Hospital

Phase N/A

People who have Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis are asked to participate in a research study being conducted by Montefiore Medical Center

Phase N/A

People who have Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) are asked to participate in a research study being conducted by Montefiore Medical Center

Phase N/A

Nonalcoholic steatohepatitis (NASH) is liver inflammation caused by a buildup of fat in the liver. ClinSearch is enrolling volunteers with NASH in a study testing the effectiveness, tolerability and safety of an investigational medication.

Phase N/A

Nonalcoholic steatohepatitis (NASH) is liver inflammation caused by a buildup of fat in the liver. Wake Research Associates is enrolling volunteers in a study testing the effectiveness, and safety of an investigational medication for individuals with NASH and associated bridging fibrosis.

Phase N/A

Nonalcoholic steatohepatitis (NASH) is liver inflammation caused by a buildup of fat in the liver. If you have a condition called compensated cirrhosis from NASH, Wake Research Associates is enrolling volunteers in a study testing the effectiveness, tolerability and safety of an investigational medication.

Phase N/A

Living with Liver Disorder? Wake Research Associates is enrolling volunteers with fatty liver disease or non-alcoholic steatohepatitis (NASH) in a clinical research study.

Phase N/A

Nonalcoholic steatohepatitis (NASH) is an advanced form of fatty liver disease. It is caused by excess fat in the liver that leads to inflammation and tissue injury. People with type 2 diabetes, obesity, high cholesterol, insulin resistance, and high blood pressure may have NASH. ACRC Trials is conducting a research ...

Phase

A phase 3 research study of an oral investigational medication as induction and maintenance therapy for adults ages 18 to 75 with moderate to severe ulcerative colitis. Note, study participants may receive the investigational medication or placebo. For more information, please visit our study website at: www.TrueNorthStudy.com

Phase

Do you have liver cirrhosis as a result of Nonalcoholic Steatohepatitis (NASH)? Participating in research is one of the best ways to actively participate in the search for a cure! Call today to learn more!

Phase N/A